Title: An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110601
Title: AdoHcy hydrolase of Trichomonas vaginalis: studies of the effects of 5'-modified adenosine analogues and related 6-N-cyclopropyl derivatives.
Journal: Bioorganic & medicinal chemistry letters 20101215
Title: Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers.
Journal: Bioorganic & medicinal chemistry 20081015
Title: Inhibition of transmethylation down-regulates CD4 T cell activation and curtails development of autoimmunity in a model system.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20070415
Title: A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Journal: The Journal of pharmacology and experimental therapeutics 20061101
Title: S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responses.
Journal: The Journal of pharmacology and experimental therapeutics 20060301
Title: Wu QL, et al. Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression. J Pharmacol Exp Ther. 2005 May;313(2):705-11.
Title: Fu YF, et al. S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responses. J Pharmacol Exp Ther. 2006 Mar;316(3):1229-37.
Title: He SJ, et al. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacol Sin. 2014 Feb;35(2):219-29.
